Your browser doesn't support javascript.
loading
Structure-Activity Relationship of pH-Sensitive Doxorubicin-Fatty Acid Prodrug Albumin Nanoparticles.
Yang, Yinxian; Li, Xiuhong; Song, Jiaxuan; Li, Lingxiao; Ye, Qing; Zuo, Shiyi; Liu, Tian; Dong, Fudan; Liu, Xiaohong; He, Zhonggui; Sun, Bingjun; Sun, Jin.
Afiliação
  • Yang Y; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Li X; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Song J; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Li L; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Ye Q; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Zuo S; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Liu T; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Dong F; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Liu X; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • He Z; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Sun B; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Sun J; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
Nano Lett ; 23(4): 1530-1538, 2023 02 22.
Article em En | MEDLINE | ID: mdl-36719151

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Pró-Fármacos / Nanopartículas / Neoplasias Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Nano Lett Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Pró-Fármacos / Nanopartículas / Neoplasias Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Nano Lett Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China